Literature DB >> 16286588

Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.

Virna L Sales1, Galina K Sukhova, Marco A Lopez-Ilasaca, Peter Libby, Victor J Dzau, Richard E Pratt.   

Abstract

BACKGROUND: In the vasculature, the angiotensin type 2 (AT2) receptor (AT2R) exerts antiproliferative, antifibrotic, and proapoptotic effects. Normal adult animals have low AT2R expression; however, vascular injury and exposure to proinflammatory cytokines augment AT2R levels. We hypothesized that AT2R expression increases during initiation and progression of atherosclerosis. METHODS AND
RESULTS: Atherosclerotic lesions of apolipoprotein (Apo) E(-/-) mice contained AT2Rs, measured by real-time polymerase chain reaction and confirmed by immunohistochemistry. To test the consequences of this expression, male ApoE(-/-), angiotensin II type 2 receptor-deficient (Agtr2-), and ApoE(-/-), wild-type (Agtr2+) mice consumed a high-cholesterol diet from 4 weeks of age. Ten weeks later, overall area and cellular composition of aortic arch lesions did not differ significantly among genotypes. After 16 weeks, ApoE(-/-)/Agtr2+, but not ApoE(-/-)/Agtr2- mice had dramatic decreases in percent positive area of macrophages, smooth muscles, lipids, and collagen. Diminished bromodeoxyuridine incorporation and increased TUNEL staining accompanied these decreases.
CONCLUSIONS: Thus, loss of AT2R during the evolution of atherosclerotic lesions augmented the extent of cellularity of atherosclerotic lesions, establishing AT2R as a modulator of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286588     DOI: 10.1161/CIRCULATIONAHA.105.541714

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.

Authors:  Hong Lu; Anju Balakrishnan; Deborah A Howatt; Congqing Wu; Richard Charnigo; Gene Liau; Lisa A Cassis; Alan Daugherty
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.

Authors:  Helmy M Siragy
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

3.  The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.

Authors:  Bryna S M Chow; Christine Koulis; Pooja Krishnaswamy; Ulrike M Steckelings; Thomas Unger; Mark E Cooper; Karin A Jandeleit-Dahm; Terri J Allen
Journal:  Diabetologia       Date:  2016-05-11       Impact factor: 10.122

4.  Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.

Authors:  Yunzhe Wang; Cong-Lin Liu; Wenqian Fang; Xian Zhang; Chongzhe Yang; Jie Li; Jing Liu; Galina K Sukhova; Michael F Gurish; Peter Libby; Guo-Ping Shi; Jinying Zhang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-01-11       Impact factor: 5.187

5.  Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo.

Authors:  Amanda K Sampson; Jennifer C Irvine; Waled A Shihata; Dragana Dragoljevic; Natalie Lumsden; Olivier Huet; Tyrone Barnes; Thomas Unger; Ulrike M Steckelings; Garry L Jennings; Robert E Widdop; Jaye P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2015-06-29       Impact factor: 8.739

Review 6.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

7.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

8.  Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Authors:  A Koïtka; Z Cao; P Koh; A M D Watson; K C Sourris; L Loufrani; A Soro-Paavonen; T Walther; K J Woollard; K A M Jandeleit-Dahm; M E Cooper; T J Allen
Journal:  Diabetologia       Date:  2009-12-03       Impact factor: 10.122

Review 9.  Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.

Authors:  Alan Daugherty; Aruna Poduri; Xiaofeng Chen; Hong Lu; Lisa A Cassis
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

10.  Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques.

Authors:  Yiannis S Chatzizisis; Michael Jonas; Roy Beigel; Ahmet U Coskun; Aaron B Baker; Benjamin V Stone; Charles Maynard; Ross G Gerrity; William Daley; Elazer R Edelman; Charles L Feldman; Peter H Stone
Journal:  Atherosclerosis       Date:  2008-08-05       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.